Literature DB >> 22884293

Factors affecting herpes simplex virus reactivation from the explanted mouse brain.

Hui-Wen Yao1, Pin Ling, Shih-Heng Chen, Yuk-Ying Tung, Shun-Hua Chen.   

Abstract

The majority of encephalitis induced by herpes simplex virus type I (HSV-1) is due to viral reactivation from latency, but few studies have investigated the factors influencing viral reactivation in the brain due to the lack of a sensitive assay. We have established an ex vivo explant assay, which induced efficient viral reactivation in the dissociated mouse brain. Applying this assay, we investigated the infection of four HSV-1 strains with varying degrees of neurovirulence in three mouse strains with different levels of susceptibility to HSV-1 infection. We found that virulent HSV-1 strains and susceptible mouse strains exhibited prolonged viral growth during acute infection, increased latent viral genomes, and efficient explant reactivation in the brain stem. Collectively, both viral neurovirulence and host susceptibility positively correlate with HSV-1 reactivation from the explanted mouse brain.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884293     DOI: 10.1016/j.virol.2012.07.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

2.  Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Authors:  Chandra M Menendez; Jeremy K Jinkins; Daniel J J Carr
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

3.  In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models.

Authors:  Yuki Nakaya; Spyridon Stavrou; Kristin Blouch; Peter Tattersall; Susan R Ross
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

4.  Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.

Authors:  Chih-Yu Huang; Hui-Wen Yao; Li-Chiu Wang; Fang-Hsiu Shen; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.

Authors:  Derek J Royer; Meghan M Carr; Ana J Chucair-Elliott; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

Review 6.  Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection.

Authors:  Chandra M Menendez; Daniel J J Carr
Journal:  J Neuroimmunol       Date:  2017-03-08       Impact factor: 3.478

7.  In vivo reactivation of latent herpes simplex virus 1 in mice can occur in the brain before occurring in the trigeminal ganglion.

Authors:  Hui-Wen Yao; Pin Ling; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

8.  Tranylcypromine reduces herpes simplex virus 1 infection in mice.

Authors:  Hui-Wen Yao; Pin-Hung Lin; Fang-Hsiu Shen; Guey-Chuen Perng; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

9.  The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.

Authors:  Derek J Royer; Meghan M Carr; Hem R Gurung; William P Halford; Daniel J J Carr
Journal:  J Immunol       Date:  2017-07-31       Impact factor: 5.422

10.  A combination of doxycycline and ribavirin alleviated chikungunya infection.

Authors:  Hussin A Rothan; Hirbod Bahrani; Zulqarnain Mohamed; Teow Chong Teoh; Esaki M Shankar; Noorsaadah A Rahman; Rohana Yusof
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.